Label: REUS NR capsule
- NDC Code(s): 83663-003-01, 83663-003-02
- Packager: REUS POLSKA SP Z O O
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated September 15, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- ACTIVE INGREDIENT
- DO NOT USE
- INACTIVE INGREDIENT
- KEEP OUT OF REACH OF CHILDREN
- PREGNANCY OR BREAST FEEDING
- WARNINGS
- QUESTIONS
- STORAGE AND HANDLING
- WARNINGS AND PRECAUTIONS
- DOSAGE & ADMINISTRATION
- INDICATIONS & USAGE
- PURPOSE
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
REUS NR
reus nr capsuleProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:83663-003 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength NICOTINAMIDE MONONUCLEOTIDE (UNII: 2KG6QX4W0V) (NICOTINAMIDE MONONUCLEOTIDE - UNII:2KG6QX4W0V) NICOTINAMIDE MONONUCLEOTIDE 600 mg Inactive Ingredients Ingredient Name Strength RESVERATROL (UNII: Q369O8926L) 150 mg Product Characteristics Color white (WHITE (C48325)) Score no score Shape CAPSULE (CAPSULE (C48336)) Size 23mm Flavor Imprint Code 732 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:83663-003-02 80 in 1 BOTTLE 07/20/2023 1 80 in 1 BOTTLE 1 NDC:83663-003-01 80 in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 07/20/2023 Labeler - REUS POLSKA SP Z O O (522592245)